BioVentrix Acquires MateraCor, Inc.
January 27, 2022
BioVentrix, a privately held medical device company focused on less invasive left-ventricle therapies, has acquired MateraCor, Inc., a Southern California start-up developing an injectable alginate-based hydrogel and delivery system (TCMR) to prevent and reverse heart failure. The deal expands BioVentrix’s product portfolio for left ventricular restoration and adds development expertise as the company builds a platform of complementary heart-failure therapies.
- Buyers
- BioVentrix, Inc.
- Targets
- MateraCor, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Aptiva Medical Acquires VeraMed Health
October 7, 2025
Healthcare Services
Aptiva Medical, a Greenleaf Ventures portfolio company, has completed the acquisition of VeraMed Health. The deal expands Aptiva’s national patient base, strengthens its referral and payor networks, and accelerates its growth in continuous glucose monitoring (CGM) distribution and home-delivery diabetes services.
-
Warburg Pincus Invests $100M in Matera
July 17, 2024
Cloud & SaaS
Warburg Pincus has made a $100 million growth investment in Matera to fund the Brazilian banking software provider’s expansion into North America and to accelerate product development. Matera, a provider of core banking, instant payments and QR code payment solutions used by more than 250 financial institutions, reported $77 million of revenue in 2023 and has a team of over 1,000 professionals.
-
Medix Biochemica Group Acquires Bioresource Technology (BRT)
June 21, 2022
Biotechnology
Medix Biochemica has acquired a 100% stake in US-based Bioresource Technology (BRT) to expand its base matrix capabilities and strengthen its presence in the United States. BRT will be integrated into Medix Biochemica’s IVD Biomaterials Business Unit (St. Louis) while operations continue in Weston, Florida, and BRT leadership will serve as strategic advisors.
-
Valo Health Acquires TARA Biosystems
April 5, 2022
Biotechnology
Valo Health has acquired TARA Biosystems, a New York City–based company specializing in human 3D tissue engineering and cardiac disease modeling, to create an integrated cardiovascular drug discovery and development platform. The deal combines TARA's in vitro cardiac models with Valo's Opal computational platform to expand Valo's capabilities in cardiovascular drug discovery and accelerate development of new therapies.
-
Cirtec Medical Acquires Cardea Catheter Innovations
July 26, 2021
Medical Devices
Cirtec Medical has acquired Cardea Catheter Innovations, a San Jose-based manufacturer of minimally invasive catheter devices and complex delivery systems. Cardea will integrate into Cirtec's NovelCath brand to expand the company's interventional capabilities across structural heart, electrophysiology, and neurovascular markets and will relocate into Cirtec's new San Jose Center of Excellence.
-
Viant Acquires Meraqi Medical
September 11, 2019
Medical Devices
Viant, a global medical device design and manufacturing services provider, has acquired Meraqi Medical, a Silicon Valley-based design, development and manufacturing firm focused on bioelectronics and minimally invasive surgical devices. The deal expands Viant's front-end design and development capabilities, adds a West Coast D&D hub, and deepens its portfolio of medtech solutions as an add-on to its PE-backed platform.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.